(1S,2S)-2-Iodocyclopropanecarboxylic acid

Catalog No. :
ACUCVF740
CAS No. :
1932315-23-5
Molecular Formula :
C4H5IO2
Molecular Weight :
211.99

IUPAC Name:(1S,2S)-2-iodocyclopropane-1-carboxylic acid

(1S,2S)-2-Iodocyclopropanecarboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$147.00Login to see priceIn stockIn stock
250mg97%$245.00Login to see priceIn stockIn stock
1g97%$490.00Login to see priceIn stockIn stock
5g97%$1470.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1S,2S)-2-Iodocyclopropanecarboxylic acid
IUPAC Name(1S,2S)-2-iodocyclopropane-1-carboxylic acid
MDL No.MFCD28016082
Molecular FormulaC4H5IO2
Molecular Weight211.99
SMILESO=C([C@H]1[C@@H](I)C1)O
InChI KeyJLDDIEQQVGNSGM-GBXIJSLDSA-N
Synonymcis-2-Iodocyclopropanecarboxylic acid | 122676-92-0 | (1S,2S)-2-Iodocyclopropanecarboxylic acid | 1932315-23-5 | (cis)2-iodocyclopropanecarboxylic acid | (1S,2S)-2-IODOCYCLOPROPANE-1-CARBOXYLIC ACID | MFCD28016082 | MFCD27501034 | SCHEMBL16943612 | XEA676
CAS No.1932315-23-5
PubChem CID75530421

Safety Data

Pictogram
CorrosiveHarmful or irritantEnvironmental hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H315-H318-H335-H410
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P362+P364-P403+P233-P501

Synthetic Route by SureRoute

1. ACUCVF740 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUCVF740 route product structure diagram
    ACUCVF7401932315-23-5 In Stock
Inquiry

2. ACUCVF740 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCOLG180 route compound structure diagram
    ACCOLG1801629125-76-3 In Stock
  2. Then
  3. ACUCVF740 route product structure diagram
    ACUCVF7401932315-23-5 In Stock
Inquiry

Comments (0)